Lv1
40 积分 2024-11-13 加入
Phase 2 study of pembrolizumab in advanced small-cell lung cancer (SCLC): KEYNOTE-158
10个月前
已关闭
Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data
10个月前
已完结
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
10个月前
已完结
皖公网安备34019202002308
